Literature DB >> 4952384

The pathogenesis of chronic lymphocytic leukemia.

D A Galton.   

Abstract

The pathogenesis of chronic lymphocytic leukemia was examined in a series of 88 cases observed during a 15-year period. In untreated cases the trend of the absolute lymphocyte counts followed two main patterns. In the type I trend, the counts rose throughout the observation period; in the type II trend, the tendency to rise ceased and the counts stabilized above and below a mean value, the stationary trend being maintained for months or years. The type II trend was associated with relatively benign disease. The development of lymphocytosis was correlated with the progression of lymphadenopathy. It is suggested that lymphocytosis may result from the physiological process of recirculation and that the accumulation of lymphocytes may result from the proliferation of a single slightly abnormal cell-line. The abnormal cells might survive an unusually long time because they are unable to respond to stimuli which cause normal lymphocytes to transform.

Entities:  

Mesh:

Year:  1966        PMID: 4952384      PMCID: PMC1936613     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  6 in total

1.  CHROMOSOME INVESTIGATIONS ON LYMPHOCYTES FROM IRRADIATED PATIENTS: EFFECT OF TIME IN CULTURE.

Authors:  K E BUCKTON; M C PIKE
Journal:  Nature       Date:  1964-05-16       Impact factor: 49.962

2.  CYTOCHEMICAL STUDIES ON CELLS FROM CHRONIC LYMPHOCYTIC LEUKAEMIA AND LYMPHOSARCOMA CULTURE WITH PHYTOHAEMAGGLUTININ.

Authors:  D QUAGLINO; D C COWLING
Journal:  Br J Haematol       Date:  1964-07       Impact factor: 6.998

3.  LYMPHOCYTE CONTENT AND PROLIFERATIVE CAPACITY OF SERIALLY TRANSPLANTED MOUSE BONE MARROW.

Authors:  G CUDKOWICZ; A C UPTON; G M SHEARER; W L HUGHES
Journal:  Nature       Date:  1964-01-11       Impact factor: 49.962

4.  The mechanism of the development of anemia in untreated chronic lymphatic leukemia.

Authors:  P WASI; M BLOCK
Journal:  Blood       Date:  1961-05       Impact factor: 22.113

5.  Determination of lymphocyte turnover by continuous infusion of H3 thymidine.

Authors:  J R LITTLE; G BRECHER; T R BRADLEY; S ROSE
Journal:  Blood       Date:  1962-02       Impact factor: 22.113

6.  Effect of urinary pH on excretion of porphyrins.

Authors:  E Bourke; P W Copeman; M D Milne; G S Stokes
Journal:  Lancet       Date:  1966-06-25       Impact factor: 79.321

  6 in total
  12 in total

1.  Lymphocyte doubling time in chronic lymphocytic leukemia modern era: a real-life study in 848 unselected patients.

Authors:  Tycho Baumann; Riccardo Moia; Gianluca Gaidano; Julio Delgado; Adalgisa Condoluci; Neus Villamor; Anil Babu Payedimarri; Dolors Costa; Andrea Patriarca; Carlos Jiménez-Vicente; Davide Rossi; Emili Montserrat
Journal:  Leukemia       Date:  2021-02-04       Impact factor: 11.528

2.  Hypercalcaemia in acute leukaemia.

Authors:  I P Palva; S J Salokannel
Journal:  Blut       Date:  1972-04

3.  Morphology of lymphatic cells and of their derived tumours.

Authors:  F Rilke; S Pilotti; A Carbone; L Lombardi
Journal:  J Clin Pathol       Date:  1978-11       Impact factor: 3.411

4.  Clinical and serological autoimmune complications in chronic lymphocytic leukemia.

Authors:  Cengiz Demir; Ömer Ekinci
Journal:  Wien Klin Wochenschr       Date:  2017-05-05       Impact factor: 1.704

5.  Death-associated Protein Kinase-1 Expression and Autophagy in Chronic Lymphocytic Leukemia Are Dependent on Activating Transcription Factor-6 and CCAAT/Enhancer-binding Protein-β.

Authors:  Padmaja Gade; Amy S Kimball; Angela C DiNardo; Priyamvada Gangwal; Douglas D Ross; H Scott Boswell; Susan K Keay; Dhananjaya V Kalvakolanu
Journal:  J Biol Chem       Date:  2016-09-02       Impact factor: 5.157

Review 6.  Chronic lymphocytic leukemia and autoimmunity: a systematic review.

Authors:  Kate Hodgson; Gerardo Ferrer; Emili Montserrat; Carol Moreno
Journal:  Haematologica       Date:  2011-01-17       Impact factor: 9.941

7.  B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome.

Authors:  Tait D Shanafelt; Neil E Kay; Greg Jenkins; Timothy G Call; Clive S Zent; Diane F Jelinek; William G Morice; Justin Boysen; Liam Zakko; Susan Schwager; Susan L Slager; Curtis A Hanson
Journal:  Blood       Date:  2008-11-17       Impact factor: 22.113

8.  CD40L/IL-4-stimulated CLL demonstrates variation in translational regulation of DNA damage response genes including ATM.

Authors:  Larissa Lezina; Ruth V Spriggs; Daniel Beck; Carolyn Jones; Kate M Dudek; Aleksandra Bzura; George D D Jones; Graham Packham; Anne E Willis; Simon D Wagner
Journal:  Blood Adv       Date:  2018-08-14

9.  The use of monoclonal antibodies in the treatment of autoimmune complications of chronic lymphocytic leukemia.

Authors:  Luca Laurenti; Barbara Vannata; Idanna Innocenti; Francesco Autore; Francesco Santini; Simona Sica; Dimitar G Efremov
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-04-10       Impact factor: 2.576

10.  The roles of age and sex in the prognosis of chronic leukaemias. A study of 373 cases.

Authors:  B Jaksić; B Vitale; E Hauptmann; A Planinc-Peraica; S Ostojic; R Kusec
Journal:  Br J Cancer       Date:  1991-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.